Centerra Gold 2018 Second Quarter Results Conference Call and Webcast

TORONTO, June 28, 2018 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (TSX:CG) (“Centerra”) will host a conference call and webcast of its 2018 second quarter financial and operating results at 10:30AM Eastern time on Wednesday, August 1, 2018.   The results are scheduled to be released before the market opens on Wednesday, August 1, 2018.

• North American participants should dial the toll-free number (877)-412-4946. 

• International participants may access the call at +1 (212)-231-2938. 

• The conference call will also be broadcast live by NASDAQ and can be accessed at Centerra Gold’s website at www.centerragold.com.

• Presentation slides of the second quarter results will also be accessible on Centerra Gold’s website at www.centerragold.com

An audio recording of the call will be available approximately two hours after the call via telephone until midnight Eastern Time on Tuesday, August 8, 2018.  The recording can be accessed by calling (416) 626-4100 or (800) 558-5253 and using the passcode 21892086.  In addition the webcast will be archived on Centerra Gold’s website www.centerragold.com.

About Centerra
Centerra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring and acquiring gold properties in North America, Asia and other markets worldwide and is the largest Western-based gold producer in Central Asia.  Centerra operates two flagship assets, the Kumtor Mine in the Kyrgyz Republic and the Mount Milligan Mine in British Columbia, Canada and is building its next gold mine, the 100% owned Öksüt Mine in Turkey.  Centerra's shares trade on the Toronto Stock Exchange (TSX) under the symbol CG.  The Company is based in Toronto, Ontario, Canada.

Additional information
Additional information on Centerra is available on the Company’s website at www.centerragold.com and on SEDAR at www.sedar.com.

For further information, please contact:
John W. Pearson
Vice President, Investor Relations
Centerra Gold Inc.
416-204-1953
john.pearson@centerragold.com

A PDF accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/931b2ed2-3580-42eb-a86a-5ca95162d393

© 2018 GlobeNewswire, Inc. All Rights Reserved.

Read More..

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.

Regeneron Pharmaceuticals' (Nasdaq: REGN) REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization